- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4164 - 1,3-Diazoles
Patent holdings for IPC class A61K 31/4164
Total number of patents in this class: 2487
10-year publication summary
|
183
|
162
|
211
|
219
|
196
|
221
|
198
|
134
|
150
|
80
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2361 |
28 |
| The Regents of the University of California | 19839 |
26 |
| Evofem Biosciences, Inc. | 47 |
19 |
| Centre National de La Recherche Scientifique | 10350 |
17 |
| F. Hoffmann-La Roche AG | 7923 |
15 |
| The Cleveland Clinic Foundation | 1574 |
15 |
| Bristol-myers Squibb Company | 4875 |
14 |
| FUJIFILM Corporation | 29251 |
14 |
| Cedars-Sinai Medical Center | 1142 |
14 |
| University of Tennessee Research Foundation | 761 |
14 |
| Novartis AG | 10883 |
13 |
| Journey Medical Corporation | 94 |
13 |
| The Regents of the University of Michigan | 4676 |
12 |
| Enanta Pharmaceuticals, Inc. | 428 |
12 |
| Pharnext | 91 |
12 |
| Abbvie Inc. | 1803 |
11 |
| The University of British Columbia | 1495 |
11 |
| Antecip Bioventures II LLC | 328 |
10 |
| Astellas Pharma Inc. | 1086 |
10 |
| Celltrion, Inc. | 324 |
10 |
| Other owners | 2197 |